Karina J. Yoon - Concepedia

Author

Karina J. Yoon

University of Alabama at Birmingham ORCID

Also Known As

K. Jin Yoon, Karina J Yoon, Karina J Yoon,, Karina J. Yoon, Karina Jin Yoon, Karina Yoon

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham Children's of Alabama St. Jude Children's Research Hospital Auburn University City Of Hope National Medical Center

About

Karina J. Yoon is an author at University of Alabama at Birmingham specializing in tumor biology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	170
2	Cell Biology	5	5	110
3	Health Sciences	1	1	29
4	Hepatology	1	1	13
5	Immunology	1	1	11

Karina J. Yoon

Publications

840

Citations

H-Index

Page 1

	Year	Citations
The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype Matthew Schultz, Andrew T. Holdbrooks, Asmi Chakraborty, Cancer Research	2016	159
Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma Mary K. Danks, Karina J. Yoon, Rebecca A. Bush, Cancer Research	2007	136
Development of a Tumor-Selective Approach to Treat Metastatic Cancer Karen S. Aboody, Rebecca A. Bush, Elizabeth Garcia, PLoS ONE	2006	125
Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma Laura L. Stafman, Adele P. Williams, Evan F. Garner, Translational Oncology	2018	51
The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma Samuel C. Fehling, Aubrey L. Miller, Patrick L. Garcia, Cancer Letters Tumor BiologyOncologyGastrointestinal OncologyMedicineHepatobiliary Tumor	2019	36
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma Laura L. Stafman, Smitha Mruthyunjayappa, Alicia M. Waters, Oncotarget	2018	30
ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma Karina J. Yoon, Doris A. Phelps, Rebecca A. Bush, PLoS ONE Membrane-actin LinkIcam-2 ExpressionMedicineCell AdhesionActin Cytoskeleton	2008	29
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth Laura V. Bownes, Adele P. Williams, Raoud Marayati, PLoS ONE PathologyCancer BiologyGliomaTumor BiologyAnti-cancer Agent	2021	29
Sphingolipid metabolism and drug resistance in ovarian cancer Kelly M. Kreitzburg, Robert C.A.M. van Waardenburg, Karina J. Yoon Cancer Drug Resistance MedicinePharmacologyAnti-cancer AgentMolecular AberrationsCancer Treatment	2018	28
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer Kelly M. Kreitzburg, Samuel C. Fehling, Charles N. Landen, Cancer Letters OncologyMedicinePharmacologyGynecologyPatient-derived Xenograft Model	2018	24

Page 1